Catalyst Wire Dossier Catalyst Wire Dossier

Aliskiren/Irbesartan combination

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aliskiren/Irbesartan combination, covering 2007-11-29 to 2007-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy [Phase 1, Phase 2]

See pricing